Stanoxyl Depot 50 - Kalpa Pharmaceuticals

Winthrop Laboratories introduced Stanozolol to the U.S. market in 1962 under the brand Winstrol. Unlike other anabolic agents, it did not convert to estrogen and provided a strong anabolic effect with oral bioavailability. Medical use included treatment of osteoporosis, wasting from chronic illness, and underdevelopment in children. Over time, regulatory tightening led to its U.S. removal. However, injectable and tablet forms continued to be produced in Europe and Latin America, especially for veterinary performance support in horses and livestock.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanoxyl Depot 50 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.